Short description
Omrix Biopharmaceuticals develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.
Description
Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Qiryat Ono, Tel Aviv, Israel, Asia
Founded on
January 1, 1995
Exited on
April 21, 2006
Went public on
April 21, 2006
Delisted on
November 24, 2008
Stock symbol
OMRI
Non-profit?
No
Acquired?
No
Employees count
501-1000
Investors
Noaccessforu, Noaccess, Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Robert Taub